• • BioWorld: “In the clinic for Dec. 21-27, 2021” (Dec. 28, 2021)
  • BioWorld: “In the clinic for Dec. 27, 2021” (Dec. 27, 2021)
  • SayB (Iraq via BBC): “What are the features of the next generation Corona vaccine?” (Dec. 27, 2021)
  • Dien Dan (Vietnam): “The world races to improve vaccines to cope with new strains” (Dec. 27, 2021)
  • 1000 ShadowBlog (China): ” The next-generation new crown vaccine is expected to be injection-free and resistant to mutations” (Dec. 27, 2021)
  • Chinese Canadian Voice: “Expectation of the next generation of new crown vaccine” (Dec. 26, 2021)
  • VN Express (Vietnam): “The race to improve the Covid-19 vaccine ” (Dec. 26, 2021)
  • Info Canada: “The next-generation new crown vaccine is expected to be free of injections and resistant to mutations” (Dec. 26, 2021)
  • NDH (Vietnam): “The race to improve the Covid-19 vaccine: Global scientists are racing to develop the next generation of vaccines to deal with Covid-19, with the expectation of significant improvements in efficacy and form” (Dec. 26, 2021)
  • Intermati (Vietnam): “The race to improve the Covid-19 vaccine” (Dec. 26, 2021)
  • TinTuc (Vietnam): “The race to improve the Covid-19 vaccine” (Dec. 26, 2021)
  • Viet BF (Vietnam): “The race to improve the Covid-19 vaccine” (Dec. 26, 2021)
  • Sydney Today (Chinese): “The next-generation new Covid vaccine” (Dec. 26, 2021)
  • Yahoo!News (Taiwan): “The next-generation Covid vaccine” (Dec. 24, 2021)
  • MingJing News: “The next-generation Covid vaccine” (Dec. 24, 2021)
  • BBC News (China): “The next-generation Covid vaccine” (Dec. 24, 2021)
  • Pharmaceutical Technology: “Coronavirus company news summary- France drops Merck’s anti-Covid-19 pill order- BiondVax signs deal for nanosized Covid-19 therapy” (Dec. 23, 2021)
  • FuntITech: “Coronavirus Company News Summary-France Withdraws Merck’s Anti-Covid-19 Pill Order-BiondVax Addresses Nano-sized Covid-19 Treatment” (Dec. 23, 2021)
  • Jewish Journal: “Orchard Cove residents volunteer to teach English as a Second Language to staff members” (Dec. 23, 2021)
  • Canton Journal Sun: “Senior cast, with ages to 101, overcome COVID restrictions to stage `Guys and Dolls’ in Canton” (Dec. 22, 2021)
  • Wicked Local Newton: “Senior cast, with ages to 101, overcome COVID restrictions to stage `Guys and Dolls’ in Canton“

(Dec. 22, 2021)

• DutchNews.nl: “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• Yahoo! Finance: “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• Le Lezard: “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• Pharmaceutical Daily: “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• Pharmaceutical Daily (Twitter): “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• BioSpace: “Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• Boston Cambridge BioTech Netwrks: “BCBN Feed: Akston Biosciences Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine in the Netherlands” (Dec. 22, 2021)
• FanFc (Russia): “Akston Biosciences received approval to conduct a Phase II/III clinical trial” (Dec. 21, 2021)
• Medical Dialogues: “Consumption of Pro-Inflammatory Diet Increases Likelihood of Frialty Onset in Older Adults” (Dec. 21, 2021)
• C&EN: “European drug service firms are changing hands: Private investors are behind deals for Seqens, Novasep, and Johnson Matthey’s business” (Dec. 20, 2021)
• PE Hub: “SK Capital buys SEQENS: SK Capital acquires SEQENS, a provider of pharmaceutical services and specialty ingredients” (Dec. 17, 2021)
• Private Equity Wire: “SK Capital Partners acquires SEQENS” (Dec. 17, 2021)
• AcroFan: “Change in SEQENS’ Shareholding Structure – SEQENS Is Now Stronger, More Focused and Positioned as One of the World’s Leading Players in Pharma” (Dec. 17, 2021)
• Yahoo!: “Change in SEQENS’ Shareholding Structure – SEQENS Is Now Stronger, More Focused and Positioned as One of the World’s Leading Players in Pharmaceutical Solutions and Specialty Ingredients” (Dec. 17, 2021)
• BizDallies: “SK Capital has acquired SEQENS, a provider of pharmaceutical solutions and specialty ingredients” (Dec. 17, 2021
• NewsCenter (Greece): “Second generation vaccines are coming, only for the rich” (Dec. 17, 2021)
• FioCruz (Brazil): “What will next-generation vaccines against covid-19 look like?” (Dec. 17, 2021)
• O Sol (Brazil): “Find out what next-generation vaccines against covid-19 will look like” (Dec. 17, 2021)
• Needham Patch: “Local senior citizens finally ‘Rock the Boat’ on opening night: Former Needham Resident among the cast that finally had their opening night” (Dec. 17, 2021)
• Canton Patch: “Local senior citizens finally ‘Rock the Boat’ on opening night: Former Needham Resident among the cast that finally had their opening night” (Dec. 17, 2021)
• Reddit: “What will tomorrow’s Covid-19 vaccines be like?” (Dec. 16, 2021)
• Dedham Patch: “Karen Tsinzo Celebrates 50 Years at HSL Dedham resident celebrates 50 years of service at Hebrew SeniorLife” (Dec. 16, 2021)
• Canton Citizen: “The Show Must Go On for the Orchard Cove Cast of ‘Guys & Dolls’” (Dec. 16, 2021)
• Digital Engineering: “How Simulation Impacts Innovation in Design Simulation brings many benefits to design engineering—but it’s not a one-size-fits-all option for certain use cases” (Dec. 15, 2021)
• W. Roxbury Patch: “Local Nurse Awarded Excellence in Leadership/Management Award: West Roxbury Resident honored by the Philippine Nurses Association of New England for work at Hebrew Rehabilitation” (Dec. 14, 2021)
• Brookline TAB: “Brookline’s COVID cases continue to climb, continued vigilance advised” (Dec. 13, 2021)
• VozMT Brazil: “What next-generation vaccines against Covid-19 will look like” (Dec. 9, 2021)
• VisionArtNews: “How will the new generation vaccines against Covid-19 be – Balance and Health” (Dec. 9, 2021)
• BBC Afrique: “Coronavirus: What will the Covid-19 vaccines of tomorrow look like?” (Dec. 8, 2021)
• The Bolivar Commercial: “What next-generation vaccines against Covid-19 will look like” (Dec. 8, 2021)
• Epoca Negocios (Brazil): “Como serão as vacinas de nova geração contra a covid-19: São inúmeros os desafios, sendo um deles a escassez de matérias-primas vitais para a fabricação dos imunizantes” (Dec. 8, 2021)
• Jornal du Dia (Brazil): “Brasil registra 233 mortes e mais de 10 mil contaminações por Covid-19 em 24h” (Dec. 8, 2021)
• Archynetys: “Consuming a diet regime of pro-inflammatory foods connected to the chance of frailty in center-aged grownups and the aged” (Dec. 8, 2021)
• MedicalXpress: “Consumption of a pro-inflammatory diet associated with increased odds of frailty in middle-aged and older adults” (Dec. 7, 2021)
• Trend Fool: “Consuming a diet of pro-inflammatory foods linked to frailty risk in middle-aged and older adults” (Dec. 7, 2021)
• El Dario NYC: “Coronavirus: what will the second generation vaccines against Covid-19 be like: The first generation of Covid-19 vaccines was developed in record time. But now scientists have bigger plans: stronger immunity, easier transport, and a mutation test” (Dec. 7, 2021)
• AZ Vision: “What will tomorrow’s Covid-19 vaccines be like?” (Dec. 6, 2021)
• La Opinon: “Coronavirus: what will the second-generation vaccines against COVID-19 be like: The first generation of Covid-19 vaccines was developed in record time. But now scientists have bigger plans: stronger immunity, easier transport, and a mutation test” (Dec. 6, 2021)
• Glas Sumadije: “Coronavirus and Vaccination: What is the Future of the Covid-19 Vaccine?” (Dec. 6, 2021)
• Espreso: “What Is the Future of Vaccines? The first generation made in record time, scientists now have more ambitious plans” (Dec. 6, 2021)
• Danas: “Coronavirus and Vaccination: What is the Future of the Covid-19 Vaccine?” (Dec. 6, 2021)
• Net.hr: “The Second Generation is Coming: What changes do the new corona vaccines bring?” (Dec. 6, 2021)
• Yahoo!Deportes: “Coronavirus: what will second-generation vaccines against covid-19 be like’ (Dec. 6, 2021)
• MDPI: “Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike” (Dec. 4, 2021)
• BBC: “What will tomorrow’s Covid-19 vaccines be like?” (Dec. 3, 2021)
• Brookline Patch: “Hebrew SeniorLife Named a Boston Globe Top Place to Work 2021:Nonprofit Senior Care Organization Ranked 24th of the Top Largest Companies” (Dec. 3, 2021)
• Top Places to Work: “Hebrew SeniorLife” (Dec. 2, 2021)
• Pharmaceutical Outsourcing: “Managing Risk in API Manufacturing is the Key to Successful Projects, Safer Drugs” (Nov. 30, 2021)
• BioWorld: “In the clinic for Nov. 23-29, 2021: Akston” (Nov. 30, 2021)
• NewsBreak: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” (Nov. 23, 2021)
• Hi India: “India Green Lights Clinical Trials Of Akston Biosciences’ Second-Generation Vaccine” (Nov. 23, 2021)
• MSN: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 23, 2021)
• The Gioingaynay (Viet Nam): “India clinical trial of second-generation Covid-19 vaccine from the US” (Nov. 23, 2021)
• Nam Dinh (Viet Nam): “India clinical trial of 2nd generation US COVID-19 vaccine” (Nov. 23, 2021)
• My Times Now: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• Free Library: “Akston doses firstx` subjects with second generation COVID-19 vaccine AKS-452 in India” (Nov. 22, 2021)
• Tin 247 News (Viet Nam): “India clinical trial of second-generation Covid-19 vaccine from the US” (Nov. 22, 2021)
• Bao Nhanh (Viet Nam): “Ấn Độ thử nghiệm lâm sàng vaccine ngừa Covid-19 thế hệ thứ 2 của Mỹ” (Nov. 22, 2021)
• PharmaBiz: “Akston Biosciences begins patient dosing in phase II trial of Covid-19 vaccine candidate, AKS-452 in India” (Nov. 22, 2021)
• The Hindu BusinessLine: “Akston Bio starts Phase II trials of Covid vax” (Nov. 22, 2021)
• We Are Net: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• ACTP News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• News Today: “India Starts Trial of US Firm’s Second-Generation Covid Vaccine” (Nov. 22, 2021)
• GK News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• Raj News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
•  CNewspedia: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• AtoZ Gujarati News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• Gielda Transportu: “Akston Bio starts Phase II trials of Covid Vax” (Nov. 22, 2021)
• Deshi News Prime: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• While News: “India starts trial of US firm’s second-generation Covid vaccine | India News” (Nov. 22, 2021)
• Times of India: “India begins trial of US firm’s second generation covid vaccine” (Nov. 22, 2021)
• Indep News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• Swachh Khabar: “India begins trial of US agency’s second-generation Covid vaccine” (Nov. 22, 2021)
• Madras Tribune: “India Starts Trial of US Firm’s Second-Generation Covid Vaccine” (Nov. 22, 2021)
• PeekinPie: “India starts trial of US firm’s second-generation“
• WiseMan Goes: “India begins trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• Voice of Asia: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• AD News Fact: “India starts trial of US firm’s 2nd-generation Covid vaccine” (Nov. 22, 2021)
• Gadgets Monster: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• News Desk: “India starts trial of US firm’s 2nd-generation Covid vaccine” (Nov. 22, 2021)
• 24×7 News: “India starts trial of US firm’s 2nd-generation Covid vaccine” (Nov. 22, 2021)
• Ural News: “India starts trial of US firm’s second-generation Covid vaccine” (Nov. 22, 2021)
• BioSpectrum: “US-based Akston Biosciences initiates Ph II trial of second-gen COVID-19 vaccine in India” (Nov. 22, 2021)
• Fuentitech: “Coronavirus Company News Summary-US FDA Extends Eligibility for Covid-19 Booster to All Adults” (Nov. 22, 2021)
• Pharmaceutical Technology: “Coronavirus company news summary – US FDA expands Covid-19 booster eligibility to all adults – EMA recommends Lagevrio pill for high risk Covid-19 patients” (Nov. 22, 2021)
• Reddit: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” (Nov. 21, 2021)
• Reddit: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 21, 2021)
• News One Place: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 21, 2021)
• TVN: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 21, 2021)
• Akeratos of Delphi: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 21, 2021)
• Forbes Middle East: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 21, 2021)
• Forbes: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 20, 2021)
• Health System Review: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 20, 2021)
• iStackr: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 20, 2021)
• Business Breaking News: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 20, 2021)
• DigiPatrix: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” Nov. 20, 2021)
• Medical Dialogues: “Covid-19: Akston Biosciences Doses FIrst Subjects in AKS-452 Study” (Nov. 20, 2021)
• BitCoin Ethereeum News: “Akston launches Covid Shot room temperature trials as next-generation vaccine race heats up” (Nov. 20, 2021)
• Twitter.com/Dr.Timos Papagatsias: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up http://dlvr.it/SCtsnf #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare” (Nov. 22, 2021)
• Twitter.com/Datos_Digital: “Akston Begins Trials For Room Temperature Covid Shot As Next-Generation Vaccine Race Heats Up” (Nov. 20, 2021)
• Pharmaceutical Daily: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” (Nov. 20, 2021)
• BioSpace: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” (Nov. 20, 2021)
• Yahoo! Finanzas: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine” (Nov. 20, 2021)
• MarTech Series: “Vortex International Launches Dream Tunnel, World’s First Fully Immersive Aquatic Attraction at IAAPA Expo” (Nov. 15, 2021)
• Yahoo! Finance: “Vortex International Launches Dream Tunnel™, World’s First Fully Immersive Aquatic Attraction at IAAPA Expo” (Nov. 15, 2021)
• Press Release.cc: “Vortex International Launches Dream Tunnel, World’s First Fully Immersive Aquatic Attraction at IAAPA Expo” (Nov. 15, 2021)
• TimesNow News: “‘Looking forward to second-gen vaccines,’ says WHO chief: From nasal sprays to multivariant jabs, vaccines in development spur hope of ending the pandemic” (Nov. 11, 2021)
• JewishBoston newsletter: “These Camp Friends Met 80 Years Ago. Now They’re Neighbors. David Rosenthal and Peter Shapiro met at Camp Alton. Now they’re living a new camp life at NewBridge on the Charles” (Nov. 1, 2021)
• JewishBoston: “These Camp Friends Met 80 Years Ago. Now They’re Neighbors. David Rosenthal and Peter Shapiro met at Camp Alton. Now they’re living a new camp life at NewBridge on the Charles” (Nov. 1, 2021)
• Boss Magazine: “The effort to get COVID vaccines to everyone” (Nov. 1, 2021)
• Chief Executive Magazine: “”Solving the Squeeze: There’s no playbook for the daunting workforce shortage businesses face now — so CEOs are creating one. These programmatic, from-the-trenches tips can help you recruit, retain and, if necessary, even revolutionize your workforce” (Oct. 18, 2021) (Pages 50-60)
• Barron’s: “A Cable Bull Goes Neutral on the Stocks. Here’s Why” (Oct. 11, 2021)
• Daily Advent: “A Cable Bull Goes Neutral on the Stocks. Here’s Why” (Oct. 11, 2021)
• FlipBoard: “A Cable Bull Goes Neutral on the Stocks. Here’s Why.” (Oct. 11, 2021)
• Newstral.com: “A Cable Bull Goes Neutral on the Stocks. Here’s Why.”(Oct. 11, 2021)
• InvestorEight: “A Cable Bull Goes Neutral on the Stocks. Here’s Why.” (Oct. 11, 2021) <: >
• Dedham Times: “Hannah Hunter awarded scholarship for second consecutive year: Residents of Hebrew SeniorLife’s NewBridhge on the Charles in Dedham offer employee scholarships” (Oct. 1, 2021)
• BioProcess Int.: “The Next COVID Challenge: Building an Arsenal of Vaccines” (Sept. 29, 2021)
• Angel Invest Boston: “Jon Hirschtick, “Innovating in the Cloud” (Sept. 15, 2021)
• Pharmaceutical Daily: “Seqens Appoints Bob Huang Managing Director of North American CDMO Operations” (Sept. 14, 2021)
• Pharmiweb: “Seqens appoints Bob Huang Managing Director of North American operations” (Sept. 14, 2021)
• BioSpace: “Seqens Appoints Bob Huang Managing Director of North American CDMO Operations” (Sept. 14, 2021)
• Canton Citizen: “Canton residents awarded scholarships from Hebrew SeniorLife communities” (Sept. 2, 2021, pg. 4)
• PitchBook: “Eurazeo to sell pharma company Seqens” (Aug. 31, 2021)
• Speciality Chemicals: “Change of owner at Seqens” (Aug. 31, 2021)
• BioPharma: “What’s the Next Wave of Covid 19 Vaccines Could Look Like” (Aug. 30, 2021)
• Roslindale Transcript-Tab: “Roslindale resident receives NewBridge on the Charles scholarship” (Aug. 30, 2021)
• BioWorld: “In the clinic for Aug. 3-9, 2021: Akston Biosciences” (Aug. 10, 2021)
• Strategic CHRO: “Lumen Crafts 6 Principles for Leading in a New Era: CHRO Scott Trezise says coaching, connectivity and inclusion are among the ways company leaders are guiding its 30,000 U.E. employees” (Aug. 24, 2021)
• Canton Citizen: “A Look Inside: Canton Citizen’s August 5 edition: Hebrew SeniorLife makes vaccine mandatory for employees” (Aug. 6, 2021)
• Pipeline Review: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine” (Aug. 6, 2021)
• Precision Vaccinations: “Protein Subunit COVID-19 Vaccine Candidate Seeks Phase 2 Participants” (Aug. 6, 2021)
• Pharmaceutical Business Review: “Akston commences dosing in Phase II trial of Covid-19 vaccine” (Aug. 6, 2021)
• Angel Invest Boston:”Todd Zion, PhD, CEO and Repeat Founder, ‘Magical Proteins'” (Aug. 6, 2021)
• BioSpace: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine” (Aug. 5, 2021)
• PharmaLeader: “Akston commences dosing in Phase II trial of Covid-19 vaccine” (Aug 5, 2021)
• Pharmaceutical Daily: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine” (Aug. 5, 2021)
• First Word Pharma: ‘Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine” (Aug. 5, 2021)
• Yahoo! Finance: “Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine ” (Aug. 5, 2021)
• Medway & Millis Town News: “Contrina Glynn Of Millis Recognized In Boston Globe’s Salute To Nurses; Hebrew SeniorLife has many opportunities for nurses to advance their careers through professional development, tuition assistance, and more” (Aug. 1, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian joins Hebrew SeniorLife” (Aug. 1, 2021)
• Jewish Journal: “From Camp Alton to NewBridge on the Charles: 70 years of friendship” (July 29, 2021)
• Contract Pharma: “Akston Biosciences, Seppic Ink Commercial Supply Agreement: Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale” (July 29, 2021)
• McKnight’s Senior Living: “Business Briefs, July 28: Hebrew SeniorLife to require current employees to receive COVID-19 vaccine by Oct. 1, new hires by start date” (July 28, 2021)
• McKnight’s Senior Living: “Educating or ‘taking a stand’? Associations differ on approach to long-term care worker COVID vaccination” (July 27, 2021)
• BioWorld: “Other news to note for July 27, 2021” (July 27, 2021)
• FirstWord Pharma: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale” (Juy 21, 2021)
• Le Lezard: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale” (July 21, 2021)
• Market Screener: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale: New data shows protein-based AKS-452 vaccine is shelf-stable for six months at 25° C (77° F)” (July 21, 2021)
• Opera News: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale” (July 21, 2021)
• DMN News: “Hebrew SeniorLife Receives the John A. Hartford Foundation 2021 Business Innovatin Award” (July 21, 2021)
• BioWorld: “Other news to note for July 21, 2021” (July 21, 2021)
• BioSpace: “Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale” (July 21, 2021)
• EenVandaag: “Tested in Groningen: easy-to-produce Akston vaccine should help vaccinate poorer countries quickly” (July 17, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian joins Hebrew SeniorLife” (July 14, 2021)
• BioWorld: “In the clinic for July 6-12, 2021 ” (July 13, 2021)
• Sikkom (The Netherlands): “Get vaccinated for 500 euros and also help the world” (July 13, 2021)
• Newsy Today: “UMCG: Hopeful first results of new corona vaccine” (July 10, 2021)
• Archytele: “UMCG: Hopeful first results of new corona vaccine” (July 9, 2021)
• Nacht Welt: “UMCG: Hoffnungsvolle erste Ergebnisse des neuen Corona-Impfstoffs” (July 9, 2021)
• Nouvelles du Monde: “UMCG: first promising results from the new corona vaccine” (July 9, 2021)
• World News Today: “UMCG: Hopeful first results of new corona vaccine” (July 9, 2021)
• BlikopNieuws: “UMCG: Hopeful first results of new corona vaccine” (July 9, 2021)
• In de Buurt: “Help develop a corona vaccine and receive €500” (July 9, 2021)
• World Today News: “UMCG: Hopeful first results of new corona vaccine” (July 9, 2021)
• Pipeline Review: “Akston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate” (July 9, 2021)
• Pharmaceutical Technology: “Coronavirus company news summary – Akston Biosciences announces positive Phase I results for Covid-19 vaccine candidate – Pfizer and BioNTech provide update on Covid-19 vaccine booster programme” (July 9, 2021)
• FuntiTech: “Coronavirus Company News Summary-Akston Biosciences Announces Phase I Positive Results for Covid-19 Vaccine Candidates” (July 9, 2021)
• NewsDay24: “Coronavirus company news summary – Akston Biosciences announces positive Phase I results for Covid-19 vaccine candidate” (July 9, 2021)
• News Fr.24: “Akston Biosciences Announces Positive Phase I Data for Second Generation COVID-19 Vaccine Candidate” (July 9, 2021)
• Clinical Trials Arena: “Akston Biosciences reports positive Phase I Covid-19 vaccine data” (July 9, 2021)
• BioWorld: “In the clinic for July 9, 2021” (July 9, 2021)
• BioWorld: “Today’s news in brief: Akston” (July 9, 2021)
• BioWorld: “Host genetics study identifies COVID-19 risk factors” (July 8, 2021)
• New York Times: “Akston Biosciences has developed a vaccine” (July 8, 2021)
• HollandOne: “Volunteers looking for a new vaccine at UMCG University Hospital Groningen in the Netherlands” (July 8, 2021)
• Zuidhorn Nueuws.nl (The Netherland): “UMCG: ‘First results of research into new corona vaccine promising‘” (July 8, 2021)
• Haren de Krant (The Netherlands): “UMCG is looking for volunteers for research into a new corona vaccine” July 8, 2021)
• Precision Vaccinations: “Another Protein Subunit COVID-19 Vaccine Candidate Found Effective” (July 8, 2021)
• Drug Development & Delivery: “Akston Biosciences Announces Positive Phase 1 Data for Second-Generation COVID-19 Vaccine Candidate” (July 8, 2021)
• BioSpace: “Akston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate” (July 8, 2021)
• BBJ on Twitter: “Just over a year after it expanded its mission well beyond insulin engineering, 10-year-old Akston Biosciences has revealed promising results from an early-stage study of its Covid-19 vaccine, which takes specific aim at thwarting variants.” (July 8, 2021)
• Boston Business News enewsletter: “Breaking News: Variant-focused Covid vaccine shows promise in early tests” (July 8, 2021)
• Boston Business Journal: “Beverly biotech shows promising Covid vaccine data, raises $19.6M” (July 8, 2021)
• Boston Cambridge Biotech Network: “Akston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate” (July 8, 2021)
• Dagblad van het Noorden (The Netherlands): “New Akston vaccine (AKS-452) can offer very good protection against corona: UMC Groningen is looking for volunteers for phase 2 research” (July 8, 2021)
• UMCG: “First results of research into new corona vaccine promising; volunteers wanted for phase 2” (July 8, 2021)
• One Page News: “Beverly biotech shows promising Covid vaccine data, raises $19.6M” (July 8, 2021)
• RTV/Noord (The Netherlands): “UMCG is looking for volunteers again for the next test phase of new corona vaccine” (July 8, 2021)
• Groninger Gezinsbode: “New Akston vaccine (AKS-452) can offer very good protection against corona: UMC Groningen is looking for volunteers for phase 2 research” (July 8, 2021)
• OogTV: “UMCG is looking for volunteers for research into a promising Covid vaccine” (July 8, 2021)
• RTV Drenthe: “UMCG: ‘First results of new corona vaccine promising’” (July 8, 2021)
• MeppelOnderneemt: “UMCG: ‘First results of new corona vaccine promising’” (July 8, 2021)
• Groningen Nuews.nl: “UMCG: ‘First results of research into new corona vaccine promising’” (July 8, 2021)
• Dagblad van het Noorden (The Netherlands): “Research: Rapid development of vaccines against corona has diverse effects: ‘You see that people observe the same phenomena, but interpret them differently’” (July 8, 2021)
• The Northern Times: “UMCG has ‘positive results’ for new US-made COVID vaccine: The AKS-452 vaccine from Akston Biosciences is now moving into phase 2 testing” (July 8, 2021)
• NOS: “UMC Groningen looking for volunteers for new vaccine” (July 8, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian has joined Hebrew SeniorLife as chief quality officer” (July 4, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian” (June 28, 2021)
• Sharon Public Access TV: “Sharon Helps: Hebrew Senior Life Orchard Cove” (June 28, 2021)
• C&EN: “Biotech firms on the shoulders of giants: Pharmaceutical services companies like Seqens, Lonza, and Evonik make many of the biotech industry’s small-molecule drugs” (June 27, 2021)
• C&EN: “Synthesizing a natural product: Mithra chooses Seqens to scale up manufacturing of an estrogen found in nature” (June 27, 2021)
• Wicked Local Concord Journal: “Hebrew SeniorLife residents participate in Jewish right of passage ceremony” (June 25, 2021)
• Wicked Local Alston-Brighton TAB: “Hebrew SeniorLife residents participate in Jewish rite of passage ceremony” (June 24, 2021)
• Brookline TAB: “Brookline Hebrew SeniorLife residents participate in Jewish Right of Passage Ceremony” (June 21, 2021)
• Sharon Patch: “Hebrew SeniorLife Residents Participate in Adult Bar Mitzvahs: Former Sharon resident who now lives at the Simon C. Fireman Community in Randolph joins 4 residents from Center Communities of Brookline” (June 21, 2021)
• Community Advocate: “Westborough nurse honored by Boston Globe” (June 17, 2021)
• EenVandaag: “Tested in Groningen: easy-to-produce Akston vaccine should help vaccinate poorer countries quickly” (June 17, 2021)
• RadioOneToday: “The current affairs program EenVandaag” (June 17, 2021)
• Marblehead Home and Style: “AKS-452: The newest vaccine: COVID-19 shot by resident’s company reaches trial stage” (Summer 2021, page 38)
• Boston Business Journal: “Form D Friday: Covid vaccine maker, female-led cancer biotech raise millions” (June 11, 2021, print edition)
• Wicked Local Plymouth: “Plymouth’s Annette White recognized in Boston Globe’s Salute to Nurses” (June 10, 2021)
• Wicked Local Easton: “Easton’s Debra Dunlap recognized in Boston Globe’s Salute to Nurses” (June 7, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian of Concord has joined Hebrew SeniorLife as chief quality officer” (June 6, 2021)
• Boston Business Journal: “Form D Friday: Covid vaccine maker, female-led cancer biotech raise millions” (June 4, 2021)
• Digital Engineering247: “The Coming of Age of AI and Machine Learning in Design: Simulation and manufacturing can benefit from AI, but adoption hurdles still exist” June 1, 2021).
• Pharmaceutical Outsourcing: “Sparking Continued Interest in Science, Post-Pandemic, Requires Raising the Next Generation of Life Sciences Talent” (May 25, 2021)
• Bedford Citizen: “Sarah Sjostrom, RN, Recognized for Outstanding Commitment at Hebrew SeniorLife’s NewBridge on the Charles Campus” (May 24, 2021)
• Opera News: “Sarah Sjostrom, RN, Recognized for Outstanding Commitment at Hebrew SeniorLife’s NewBridge on the Charles Campus” May 24, 2021)
• Mass Senior Care Association: “MSCA Members Recognized in 2021 Boston Globe Salute to Nurses” (May 24, 2021)
• Bellingham Reports: “Briefs on local businesspeople, including Robert J. Balderson, Pablo Campos, Thomas Harmon and Kevin Schneider” (May 23, 2021)
• Milford Daily News: “Movers & Shakers: Jennifer Derkazarian of Concord has joined Hebrew SeniorLife as chief quality officer” (May 23, 2021)
• Canton Journal: “Canton, Randolph residents recognized in Boston Globe’s Salute to Nurses” (May 21, 2021)
• Transcript-TAB: “West Roxbury, Roslindale nurses recognized in Boston Globe’s Salute to Nurses” (May 20, 2021)
• Wicked Local Needham: “Needham’s Tatyana Arber recognized in Boston Globe’s Salute to Nurses” (May 14, 2021)
• Newton Patch: “This Weekend’s Newton Area Events” (May 14, 2021)
• Roslindale Patch: “So Now What? A Webinar for Caregivers of Aging Parents” (May 14, 2021)
• Canton Community TV: “In the Spotlight: Dr Pascual-Leone on Alzheimer’s and Dementia:  Neurologist Alvaro Pascual-Leone, MD, PhD, Harvard Medical School Professor and Senior Scientist at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife discusses Alzheimer’s Disease and dementia. Repeats Thursday-Wed.(May 13-19) 8 AM, 2 PM, 8 PM, Midnight” (May 13-19, 2021)
• McKnight’s Senior Living: “People in the News, May 11: Hebrew SeniorLife hires Ann Masterson as vice president” (May 11, 2021)
• Milford Daily News: “Movers & Shakers: Hebrew SeniorLife announces Jennifer Derkazarian of Concord joins as chief quality officer” (May 9, 2021)
• Canton Community TV: “In the Spotlight: Dr Pascual-Leone 2021” (May 6, 2021)
• Osteoporosis Blog: “Jamaica Plan Scientist at Forefront of Osteoporosis Research Shares Tips for Prevention” (May 5, 2021)
• Jamaica Plain News: “Jamaica Plain Scientist at Forefront of Osteoporosis Research Shares Tips for Prevention” (May 5, 2021)
• McKnight’s Senior Living: “People in the news, May 4: Hebrew SeniorLife appoints Jennifer Derkazarian chief quality officer” (May 4, 2021)
• Newton TAB: “OPINION: Tips for healthy bones to reduce risk of osteoporosis” (April 30, 2021)
• NursingZone: “Celebrating Nurses Month 2021: ‘You Make a Difference’; For the second year, National Nurses Month has replaced Nurses Week, expandin the opportunity to celebrate and educate” (April 29, 2021)
• Industrial Evolution: “The Evolving Role of SaaS & Cloud in Manufacturing with PTC” (April 27, 2021)
• Boston Harbor Angels: “AKS-452: The newest vaccine – COVID-19 shot developed by Beverly company reaches trial stage” (April 20, 2021)
• RT Magazine: “Clinical Trial Begins for 2nd-Gen COVID-19 Vaccine” (April 19, 2021)
• Yahoo!News: “AKS-452: The newest vaccine” (April 19, 2021)
• Yahoo!: “AKS-452: The newest vaccine” (April 19, 2021)
• Boston Business Journal: “Waltham biotech raises $336M for new Covid-19 drug” (April 19, 2021)
• OperaNews: “AKS-452: The newest vaccine” (April 19, 2021)
• Salem News: “AKS-452: The newest vaccine;  COVID-19 shot developed by Beverly company reaches trial stage” (April 19, 2021)
• Salem News: “AKS-452: The newest vaccine”  (April 19, 2021)
• Eagle-Tribune: “COVID-19 vaccine developed by Beverly company reaches trial stage” (April 19, 2021)
• Bourgondischelatifstyle.com: “AKS-452: The newest vaccine   | Local News” (April 19, 2021)
• Boston Business Journal: “Small, local biotechs make progress on their own Covid-19 drugs” (April 16, 2021)
• Zach Stanley on Twitter: “Massachusetts leading the way, as usual! #stateofpossible“
• Don Seiffert on Twitter: “As the #COVID19 pandemic continues around the globe, small Massachusetts biotech are developing potential vaccines and treatments of their own. Two of them — @AdagioTx & Akston Biosciences — hit milestones in that process this week, reports @BosBizRowan” (April 16, 2021)
• Rowan Walrath on Twitter: “As major players dominate the headlines, smaller biotechs are plugging away at their own vaccines and treatments for Covid-19. Two local ones, @AdagioTx and Akston Biosciences, hit milestones this week: t.co/vBEKo5FHCL” (April 16, 2021)
• Greg Ryan (BBJ) on Twitter: “As major players dominate the headlines, smaller biotechs are plugging away at their own vaccines and treatments for Covid-19. Two local ones, @AdagioTx and Akston Biosciences, hit milestones this week: t.co/vBEKo5FHCL” (April 16, 2021)
• The Scientist: “Track COVID-19 Vaccines Advancing Through Clinical Trials” (April 15, 2021)
• Pre-IPO Pharma: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 15, 2021)
• Drug Discovery Today: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 15, 2021)
• BioCalifornia on Twitter: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine https://bit.ly/3tqkOmP” (April 15, 2021)
• Top Dutch: “All a bike ride away: Meet the tight-knit ecosystem fast tracking COVID vaccine development” (April 15, 2021)
• Top Dutch on Facebook: “Fast tracking vaccine development” (April 15, 2021)
• Top Dutch on Twitter: “Fast tracking vaccine development – This week TRACER began trials for Akston Biosciences’ COVID vaccine – a possible game changing candidate – at @umcg” (April 15, 2021)
• Clinical Trials Arena: “Akston Biosciences doses first patient with next-gen Covid-19 vaccine: Akston Biosciences has dosed the first participant to receive its vaccine candidate, AKS-452, in a Phase I/II trial in the Netherlands” (April 14, 2021)
• Clinical Trials Arena on Twitter: “Akston Biosciences doses first patient with next-gen Covid-19 vaccine” (April 14, 2021)
• Biosimilars on Twitter: “Akston Biosciences takes second-generation COVID-19 vaccine into Phase 1/2 clinical trial” (April 13, 2021)
• BioWorld: “In the clinic for April 6-12, 2021” (April 13, 2021)
• Canton Community TV: “In the Spotlight-Alegria Cohen on Malnutrition in Seniors” (April 13, 2021)
• BioPharma Reporter: “Akston Biosciences takes second-generation COVID-19 vaccine into Phase 1/2 clinical trial” (April 13, 2021)
• Le Lezard: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 12, 2021)
• RepublicWorld.com (India): “Akston Biosciences Launches Phase I/II Clinical Trial Of Second-Generation COVID-19 Vaccine: Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first participants have been dosed in an open-label trial of AKS-452, its COVID-19 vaccine candidate” (April 12, 2021)
• Pharmaceutical Daily: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 12, 2021)
• Pharmaceutical Daily on Twitter: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 12, 2021)
• BioWorld: “China says COVID-19 vaccine efficacy is ‘not high; Also in the news: Akston” (April 12, 2021)
• The Science Advisory Board: “Akston begins 2nd-generation COVID-19 vaccine trial” (April 12, 2021)
• PharmaRegNews: “Akston Biosciences Launches Phase I/II Clinical Trial of COVID-19 Vaccine shelf-stable for 4 months at temperatures up to 25°C (77°F)” (April 12, 2021)
• Dagblad Noorden (The Netherlands): “Volunteers receive an experimental corona vaccine at the UMCG in Groningen. It is being tested on humans for the first time. The experimental Akston vaccine goes for the first time in a human arm at the UMCG” (April 12, 2021)
• BioSpace: “Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine” (April 12, 2021)
• BioWorld: “In the clinic for April 12, 2021” (April 12, 2021)
• Benzinga: “Lumen Technologies Shares Up 0.7% Ahead Of Co.’s Analyst Day Wednesday, Starting At 12 p.m. EDT” (April 7, 2021)
• WeBull: “Lumen Technologies Shares Up 0.7% Ahead Of Co.’s Analyst Day Wednesday, Starting At 12 p.m. EDT” (April 7, 2021)
• MarketWatch: “T-Mobile, AMD, Levi Strauss, Constellation Brands, and Other Stocks for Investors to Watch This Week” (April 4, 2021)
• Campus Groningen: “The company Tracer (a contract research organization) on Campus Groningen is going to research a candidate vaccine against Covid-19 together with the UMCG” (April 6, 2021)
• Barron’s: “T-Mobile, AMD, Levi Strauss, Constellation Brands, and Other Stocks for Investors to Watch This Week” (April 4, 2021)
• MarketWatch: “With Vaccines and Relief Checks on Tap, Consumers Want to Shop. Here’s What They’re Thinking.” (April 2, 2021)
• Barron’s: “With Vaccines and Relief Checks on Tap, Consumers Want to Shop. Here’s What They’re Thinking.” (April 2, 2021)
• TomorrowScale: “Virtual Recovery: Dr. John Krakauer” (April 1, 2021)
• Veriety Info (The Netherlands): “More than 1,500 registrations for the test with the new crown vaccine at UMCG” (March 20, 2021)
• De Eemslander (The Netherlands): “UMCG is investigating corona vaccine” (March 20, 2021)
• Newsy Today: “More than 1,500 people want to test a new corona vaccine at UMCG” (March 20, 2021)
• News Beezer (The Netherlands): “More than 1500 registrations for a test with a new corona vaccine at UMCG” (March 20, 2021)
• OOZO (The Netherlands): “More than 1,500 people want to test new corona vaccine at UMCG“
• Nach Welt (The Netherlands): “More than 1,500 people want to test a new corona vaccine at UMCG” (March 19, 2021)
• Nouvelles du Monde: “More than 1,500 people want to test new corona vaccine at UMCG” (March 19, 2021)
• OOGTV (The Netherlands): “More than 1,500 people want to test a new corona vaccine at UMCG” (March 19, 2021)
• NotiUlti (The Netherlands): “More than 1500 registrations for a trial with a new corona vaccine at UMCG” (March 19, 2021)
• NotiUlti (The Netherlands): “UMCG is looking for volunteers to test the American corona vaccine (update)” (March 19, 2021)
• Een Vandaag (The Netherlands): “Better, faster and more accessible than AstraZeneca, Moderna and Janssen: 264 more corona vaccines are in the works” (March 19, 2021)
• Dagblad Noorden (The Netherlands): “More than 1500 registrations for a test with a new corona vaccine at UMCG” (March 19, 2021)
• RTV Noord: “More than 1500 people want to test American corona vaccine at UMCG” (Mrch 19, 2021)
• The Northern Times: “UMCG to launch new Coronavirus vaccine human trials” (March 19, 2021)
• EenVandaag: “Better, faster and more accessible than AstraZeneca, Moderna and Janssen: 264 more corona vaccines are in the works” (March 19, 2021)
• NotiUlti (The Netherlands): “UMCG is looking for volunteers to test the American corona vaccine (update)” (|March 19, 2021)
• News Groningen (The Netherlands): “More than 1500 registrations for a test with a new corona vaccine at UMCG” (March 19, 2021)
• Nachedeu:(Russia) “UMCG studies candidate vaccine against COVID-19 and seeks volunteers | RIGHT NOW” (March 19, 2021)
• Medical Facts (The Netherlands): “UMCG is investigating candidate vaccine AKS-452 against corona and is looking for volunteers” (March 19, 2021)
• Zorg Nieu: “UMCG is investigating candidate vaccine AKS-452 against corona and is looking for volunteers” March 19, 2021)
• Groningen Onderneemt (The Netherlands): “UMCG is investigating candidate vaccine against COVID-19 and is looking for volunteers” March 18, 2021)
• FTO.Nu: “UMCG is investigating candidate vaccine against corona and is looking for volunteers” March 18, 2021)
• FUCAA: “LIVE UMCG is looking for volunteers to test a new crown vaccine Abroad” (March 18, 2021)
• De Telegraaf: “‘Select number of Dutch people may test American corona vaccine (and receive 500 euros)‘” (March 18, 2021)
• Nationale Zorggids (The Netherlands): “UMCG is looking for volunteers to research a candidate vaccine against coronavir” (March 18, 2021)
• Nouvelles du Monde: “UMCG is looking for a candidate vaccine against COVID-19 and is looking for volunteers | NOW” (March 18, 2021)
• News Splinter (The Netherlands): “Het UMCG zoekt vrijwilligers om een ​​nieuw coronavirusvaccin te testen Buitenland” (March 18, 2021)
• NRC.nl (The Netherlands): “UMCG is looking for candidates to test new corona vaccine” (March 18, 2021)
• Eemsbode (The Netherlands): “UMCG zoekt vrijwilligers om mogelijk nieuw coronavaccin van Akston Biosciences te testen” (March 18, 2021)
• Aphasiarc: “UMCG is looking for volunteers to test new corona vaccine” (March 18, 2021)
• OmroepWest (The Netherlands) “UMCG is looking for volunteers to test new corona vaccine” (March 18, 2021)
• SKI.PR: “UMCG is investigating vaccine against Covid-19“
• Veriety Info (The Netherlands): “UMCG is looking for volunteers to test the American crown vaccine (update)” (March 18, 2021)
• EEMSKrant.NL: “UMCG is looking for volunteers for a candidate vaccine against corona” (March 18, 2021)
• News Beezer: “UMCG is looking for volunteers to test the American corona vaccine (update)” (March 18, 2021)
• NOS (The Netherlands): “UMCG is looking for volunteers for vaccine candidates” (March 18, 2021)
• RTV on Nord (The Netherlands): “Babette on North” (approx. 39:30) (March 18, 2021)
• RTV on Nord (The Netherlands): “UMCG is looking for volunteers to test American corona vaccine (update)” (March 18, 2021)
• RTV Drenthe (The Netherlands): “UMCG is looking for volunteers to test new corona vaccine” (March 18, 2021)
• Het Dagblad van het Noorden (The Netherlands):”Not yet ready for a shot? Residents of Drenthe, Groningen and Friesland can test American corona vaccine without a genetic code (and receive 500 euros)” (March 18, 2021)
• Het Dagblad van het Noorden (The Netherlands): “UMCG is looking for volunteers to possibly test new corona vaccine from Akston Biosciences” (March 18, 2021)
• Het Dagblad van het Noorden (The Netherlands): “UMCG is looking for volunteers to possibly test new corona vaccine from Akston Biosciences” (March 18, 2021)
• News Groningen: “Select number of Dutch people may test American corona vaccine (and will receive 500 euros)” (March 18, 2021)
• De Telegraaf (The Netherlands): “LIVE | UMCG is looking for volunteers to test new corona vaccine” (March 18, 2021)
• Groniger Internet Courant: “UMCG is investigating candidate vaccine against corona and is looking for volunteers” (March 18, 2021)
• En24: “UMCG is researching candidate vaccine against COVID-19 and is looking for volunteers | NOW” (March 18, 2021)
• NU.nl (The Netherlands): “UMCG is investigating candidate vaccine against COVID-19 and is looking for volunteers” (March 18, 2021)
• Netherlands News Live: “UMCG is investigating candidate vaccine against corona and is looking for volunteers” (March 18, 2021)
• Wayland Town Crier: “Wayland doctor: Six lifestyle components to sustain brain health” (March 13, 2021)
• News Break: “Wayland doctor: Six lifestyle components to sustain brain health” (March 13, 2021)
• World Today News: “UMCG is looking for volunteers to possibly test new corona vaccine from Akston Biosciences” (March 18, 2021)
• University of Groningen: “UMCG to study potential coronavirus vaccine: volunteers sought ” (March 18, 2021)
• Jewish Journal: “Hebrew SeniorLife’s Orchard Cove pilot tests help shape the reopening of schools,” p. 17 (March 11, 2021)
• Brookline TAB: “A look back: COVID in Brookline, one year later” (March 11, 2021)
• Pharmaceutical Outsourcing: “CDMO Audits Should Be a Key Part of Quality Processes in Drug Development” (March 4, 2021)
• Peabody Weekly News: “Giving the gift of memory” (March 4, 2021)
• Dorchester Reporter: “Dot native, wife give $5m to boost ‘memory health’ at Hebrew SeniorLife Center” (March 4, 2021)
• NewsBreak: “Local couple donates $5M to fight Alzheimer’s” (March 2, 2021)
• Lynn Daily Item: “Local couple donates $5M to fight Alzheimer’s” (March 2, 2021)
• Daily Item on Twitter: “Front Page: Couple Donates $5M to Fight Alzheimer’s” (March 2, 2021)
• Item Live: “Local Couple Donates $5M to Fight Alzheimer’s” (March 1, 2021)
• C&EN: “Investment spreads at US pharma service firms: Tight capacity and government initiatives are cited as spurs for fresh investment” (Feb. 25, 2021)
• The Science Advisory Board: “Clinical pipeline promises effective 2nd-generation COVID-19 vaccines” (Feb. 25, 2021)
• Sharon Public Access TV: “Sharon Helps Orchard Cove Hebrew SeniorLife” (Feb. 24, 2021)
• Chemistry Today: “Quality and Supply Chain Security: Supply Chain Risk, Rising Drug Prices and Growth of Start-Us Among Key Trends to Watch in 2021: Five Key Factors Impacting the Life Science Sector” (Jan./Feb. 2021)
• Sharon Public Access TV: “Sharon Helps Orchard Cove Hebrew SeniorLife” (Feb. 23, 2021)
• PharmaLive: “Pharma Poised for Continued Growth in 2021 Driven by Lessons Learned From COVID-19” (Feb. 22, 2021)
• Biotech Capital: “Dechra Pharmaceuticals expects year to be first-half weighted as pre-Brexit inventory build unwinds” (Feb. 22, 2021)
• ProActive Investors: “Dechra Pharmaceuticals expects year to be first-half weighted as pre-Brexit inventory build unwinds The outlook for the full year remains positive, with ‘strong favourable’ market conditions to remain” (Feb. 22, 2021)
• Canton Community TV: “In The Spotlight: The MIND Diet” (Feb. 20, 2021)
• Internet Archive: “In The Spotlight: The MIND Diet” (Feb. 20, 2021)
• DCAT Value Chain Insights: “Fine Chemicals: Which CDMOs/CMOs Are Expanding?: Seqens” (Feb. 17, 2021)
• Talkin’ Pets Radio: “Talking’ Pets News for Feb. 13” (Feb. 13, 2021)
• Talkin’ Pets: “Talkin’ Pets Podcast for Feb. 13” (Feb. 13, 2021)
• Fierce Pharma: “French API maker Seqens primed for sale to the tune of $2.4B: report” (Feb. 10,2021)
• Winway: “French API maker Seqens primed for sale to the tune of $2.4B: report” (Feb. 10, 2021)
• Yahoo!Money: “Akston Biosciences Signs Licensing Agreement with Dechra Pharma for AKS-425c, a Once-a-Week Insulin Therapy for Cats” (Feb. 9, 2021)
• Owler: “Akston Biosciences : Signs Licensing Agreement with Dechra Pharma for AKS-425c, a Once-a-Week Insulin Therapy for Cats” (Feb. 9, 2021)
• New Equipment Digest: “What’s Ahead for Product Development & Innovation in 2021: Four industry predictions from a manufacturing-tech strategist” (Feb. 2, 2021)
• Brookline Tab: “Here’s how to schedule your COVID-19 vaccine appointment” (Jan. 29, 2021)
• Georgetown Record-Citizen: “Georgetown COA helps seniors navigate COVID-19 vaccine chaos” (Jan. 29, 2021)
• Wicked Local Georgetown: “Mel Schnall, a current resident of Hebrew SeniorLife’s Orchard Cove who formerly lived in Newton, is one of more than 2,000 patients, residents and staff at campuses throughout Greater Boston to receive a COVID vaccine since Dec. 30” (Jan. 29, 2021)
• Canton Journal-Sun: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• MetroWest Daily News: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Newton: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Weston: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Dedham: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Brookline: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Needham: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Wellesley: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Wicked Local Sharon: “Canton’s Orchard Cove residents receive COVID-19 vaccine” (Jan. 29, 2021)
• Sharon Public Access TV: “Sharon Helps: Growing Old Together” (Jan. 27, 2021)
• CommPro.Biz: “7 Media Trends for 2021 include Supply Chains, Healthcare, Telepresence and Customer Experiences” (Jan. 25, 2021)
• CommProBiz Headlines: “7 Media Trends for 2021; Natural Light Imitates Art; Facing a Career or Life Change?; DAVOS Update” (Jan. 25, 2021)
• IndustryWeek: “What’s Ahead for Product Development & Innovation in 2021: Four industry predictions from a manufacturing-tech strategist” (Jan. 22, 2021)
• IndustryWeek: Daily Headlines: Afternoon Edition: “What’s Ahead for Product Development & Innovation in 2021: Four industry predictions from a manufacturing-tech strategist” (Jan. 22, 2021)
• Bulldog Reporter: “7 media and marketing trends to watch in 2021” (Jan. 21, 2021)
• NewTV: “Living Their Best Lives: Alba and Bob Tutnauer at NewBridge on the Charles” (Jan.. 20, 2021)
• BioPharma Reporter: “In the pipeline: What the next wave of COVID-19 vaccines could look like: Akston Biosciences’s room temperature stable vaccine (AKS-452)” (Jan. 20, 2021)
• BioWorld: “Other news to note for Jan. 12, 2021” (Jan. 12, 2021)
• Pharmaceutical Outsourcing Newsletter: “Akston Biosciences Announces Manufacturing Partner for COVID-19 Vaccine” (Jan. 12, 2021)
• Pharmaceutical Outsourcing: “Akston Biosciences Announces Manufacturing Partner for COVID-19 Vaccine” (Jan. 11, 2021)
• Pharma News: “Covid-19 development round-up: January 8, 2021” (Jan. 8, 2021)
• Opera News: “LakePharma announces it will develop, produce COVID vaccine at South Street facility” Jan. 8, 2021)
• Pharmaceutical Business International: “Akston and LakePharma to manufacture second-gen COVID-19 vaccine” (Jan. 8, 2021)
• DCAT Value Chain Insights: “CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects” (Jan. 7, 2021)
• eHop on Twitter: “LakePharma announces it will develop, produce COVID vaccine at South Street facility – Hopkinton Independent” (Jan. 7, 2021)
• eHop: “Hopkinton might end up playing a key role in helping to end the COVID-19 pandemic, as the biotech company LakePharma announced that it will work to develop and produce a vaccine at its facility on South Street” (Jan. 7, 2021)
• Hopkinton Indepedent on Twitter: “Good morning Hopkinton, here is your daily update. Read about the important role LakePharma may play in the fight against COVID-19 and see which popular town eatery is closing for the winter. Also, see the sign of peace from a Hayden Rowe family and don’t miss tonight’s Open Space Preservation Commission meeting” (Jan. 7, 2021)
• Hopkinton Independent on Facebook: “Hopkinton could soon help produce and distribute a new, more stable COVID-19 vaccine currently in development. Learn more about the biotech partnership making this possible…” (Jan. 6, 2021)
• MBI Incubators on Twitter: “Congratulations to @LakePharma ! Leading the way to recovery for #COVID19 #MBIGrads #ScienceLeadsTheWay #BiomedicalCorridor” (Jan. 6, 2021)
• Worcester Business Journal on Facebook: “The biotech company LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine and produce it at its Hopkinton facility” (Jan. 6, 2021)
• ESM Central Schools: “We are proud of ESM Alum Todd Zion (’93)! He’s the president/CEO Akston Biosciences, which is ramping up efforts for a room temperature COVID-19 vaccine: ‘A vaccine for everywhere & everyone in the world.’ (Jan. 6, 2021)
• Research and Markets: “Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape” (Jan. 6, 2021)
• PharmaLeaders: “LakePharma to manufacture Akston Biosciences’ Covid-19 vaccine” (Jan. 6, 2021)
• NewsBreak: “Akston Biosciences and LakePharma team up on second-generation COVID-19 vaccine” (Jan. 6, 2021)
• Hopkinton Independent: “LakePharma announces it will develop, produce COVID vaccine at South Street facility” (Jan. 6, 2021)
• Worcester Business Journal: “LakePharma signs partnership to manufacture COVID-19 vaccine candidate in Hopkinton” (Jan. 6, 2021)
• Worcester Business Journal on Twitter: “The biotech company LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine and produce it at its Hopkinton facility” (Jan. 6, 2021)
• Grant Welker on Twitter: “The biotech firm LakePharma has signed a partnership agreement with a North Shore therapeutics company to jointly develop a potential COVID-19 vaccine at its Hopkinton facility” (Jan. 6, 2021)
• Pharmaceutical Daily: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 6, 2021)
• Pharma Focus Asia: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 6, 2021)
• World Pharma Today: “Akston Biosciences and LakePharma Enter Covid-19 Partnership” (Jan. 6, 2021)
• M2 Pharma: “Akston Biosciences partners with LakePharma to manufacture second-generation COVID-19 vaccine, AKS-452” (Jan. 6, 2021)
• M2 Pharma: “Akston Biosciences collaborates with LakePharma to develop commercial quantities of Akston’s COVID-19 vaccine candidate” (Jan. 6, 2021)
• Pharmaceutical Business Review: “LakePharma to manufacture Akston Biosciences’ Covid-19 vaccine” (Jan. 6, 2021)
• Baker: “Supporting Science in a World of COVID-19: Akston Biosciences & LakePharma” (Jan. 6, 2021)
• Pharmaceutical Technology: “Akston Biosciences and LakePharma to manufacture Covid-19 vaccine : Akston Biosciences has established a strategic partnership with US-based Biologics CRDMO LakePharma to manufacture second-generation Covid-19 vaccine” (Jan. 6, 2021)
• Pipeline Review: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 6, 2021)
• Drug Discovery & Development on Twitter: “An inexpensive investigational #Vaccine is stable for weeks at room temperature & can potentially be used for both prime & boost #Vaccination. Developer Akston #Biosciences, has hooked up with @LakePharma to #Manufacture it https://drugdiscoverytrends.com/akston-biosciences-and-lakepharma-team-up-on-second-generation-covid-19-vaccine/… #ClinicalTrials @researchumcg” (Jan. 6, 2021)
• Drug Discovery & Development: “Akston Biosciences and LakePharma team up on second-generation COVID-19 vaccine” (Jan. 5, 2021)
• BioPharma-Reporter: “Akston ramps up efforts for room temperature COVID-19 vaccine: ‘A vaccine for everywhere and everyone in the world’” (Jan. 5, 2021)
• Contract Pharma: “Akston Biosciences and LakePharma Enter Covid-19 Partnership: Will manufacture second-generation COVID-19 vaccine, AKS-452” (Jan. 5, 2021)
• DDN on LinkedIn: “#CRDMO LakePharma, Inc. to manufacture Akston Biosciences Corporation’s #COVID19 #vaccine AKS-452 for Phase 1/2 #ClinicalTrials. Shelf-stable Fc fusion vs #SARSCoV2 #spike #RBD designed to induce mixed Th1/Th2 #immune response” (Jan. 5, 2021)
• DDN on Twitter: “#CRDMO LakePharma, Inc. to manufacture Akston Biosciences Corporation’s #COVID19 #vaccine AKS-452 for Phase 1/2 #ClinicalTrials. Shelf-stable Fc fusion vs #SARSCoV2 #spike #RBD designed to induce mixed Th1/Th2 #immune response” (Jan. 5, 2021)
• BioSpace: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• BioWorld: “Other news to note for Jan. 5, 2021: Akston Biosciences Inc.” (Jan. 5, 2021)
• BioWorld: “Change to COVID-19 vaccine dosing schedule stirs debate” (Jan. 5, 2021)
• IMPharma News: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• PBOA on Twitter: “Non-member news: Akston Biosciences and @LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• Pharmaceutical Today: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• Manufacturing on Twitter: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• Pharmaceutical Marketing Grooup: “Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine” (Jan. 5, 2021)
• BioPortfolio on Twitter: “http://bioportfolio.co.uk Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine http://dlvr.it/RpxzYJ #marketresearch #reports #data” (Jan. 5, 2021)